Given the high frequency of TP53 mutations and their presence in nontumor cells, patients should be evaluated for germline TP53 mutations and Li-Fraumeni syndrome and, if identified, offered genetic counseling [176,177]. Here, TP53 is linked to Li-Fraumeni syndrome.